Pious Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 9 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 3.03%
(FY 2023)
- Profit 204.65%
(FY 2023)
- Ebitda 232.82%
(FY 2023)
- Net Worth 28.81%
(FY 2023)
- Total Assets 139.89%
(FY 2023)
About Pious Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vineet Patel and Dinesh Patel serve as directors at the Company.
- CIN/LLPIN
U33120GJ2015PTC085499
- Company No.
085499
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pious Biotech Private Limited offer?
Pious Biotech Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Cleanroom Equipment & Supplies, Clean Room Equipment, Pass Box, Home Appliances & Kitchen Appliances, Air Purifier, UV Chamber, Dynamic Pass Box, Vertical Laminar Airflow.
Who are the key members and board of directors at Pious Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vineet Patel  | Whole-Time Director | 28-Dec-2015 | Current |
| Dinesh Patel | Whole-Time Director | 28-Dec-2015 | Current |
Financial Performance of Pious Biotech.
Pious Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.03% increase. The company also saw a substantial improvement in profitability, with a 204.65% increase in profit. The company's net worth Soared by an impressive increase of 28.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pious Biotech?
In 2023, Pious Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ultra Airtech Private LimitedActive 20 years 30 daysVineet Patel and Dinesh Patel are mutual person
- Djk Industries Private LimitedActive 24 years 9 months
Vineet Patel and Dinesh Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pious Biotech?
Unlock and access historical data on people associated with Pious Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pious Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pious Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
